Literature DB >> 6769329

Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation.

J R Wilson, N Reichek, J Hirshfeld.   

Abstract

Afterload reduction in chronic asymptomatic aortic regurgitation might retard left ventricular enlargement and hypertrophy and, consequently, delay the onset of myocardial dysfunction and the need for surgical intervention. Since afterload is best expressed as wall stress, the effect of nitroglycerin on wall stress was determined in 10 normal subjects and in eight asymptomatic subjects with aortic regurgitation and normal left ventricular and circulatory function. Peak and end-systolic wall stress were estimated using a noninvasive echocardiographic technique. At rest, despite significantly larger left ventricular dimensions in the subjects with aortic regurgitation, peak systolic wall stress in this group (134 +/- 29 X 10(3) dynes/cm2) was similar to that in normal subjects (134 +/- 26 X 10(3) dynes/cm2). In contrast, end-systolic wall stress was higher in aortic regurgitation (84 +/- 12 versus 59 +/- 15 X 10(3) dynes/cm2) (P less than 0.01). Following the administration of nitroglycerin, the subjects with aortic regurgitation had larger reductions in left ventricular end-diastolic (3.5 mm) and end-systolic (3.1 mm) dimensions than did the normal subjects (0.6 and 1.1 mm, respectively), despite similar changes in blood pressure. This resulted in normalization of end-systolic wall stress and in reduction of peak systolic wall stress below normal in aortic regurgitation. We conclude that (1) nitroglycerin offers a simple and effective means of acutely reducing afterload in asymptomatic aortic regurgitation; (2) left ventricular dimensional changes after the administration of nitroglycerin are larger in subjects with aortic regurgitation than in normal subjects. Consequently, unloading therapy may be effective in protecting the left ventricle in this disorder.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769329     DOI: 10.1016/0002-9343(80)90252-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Cardiovascular effects of a single slow release lanreotide injection in patients with acromegaly and left ventricular hypertrophy.

Authors:  F Manelli; P Desenzani; E Boni; G Bugari; F Negrini; G Romanelli; V Grassi; A Giustina
Journal:  Pituitary       Date:  1999-11       Impact factor: 4.107

2.  Pressure-Strain Loops, a Novel Non-invasive Approach for Assessment of Children with Cardiomyopathy.

Authors:  Doaa M Aly; Michael Nguyen; Scott Auerbach; Christopher Rausch; Bruce Landeck; Michael V DiMaria
Journal:  Pediatr Cardiol       Date:  2022-04-11       Impact factor: 1.838

3.  Left heart function in chronic obstructive lung disease.

Authors:  H Seibold; U Roth; R Lippert; J Kohler; S Wieshammer; E Henze; M Stauch
Journal:  Klin Wochenschr       Date:  1986-05-02

4.  Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease.

Authors:  Rathika Krishnasamy; Nicole M Isbel; Carmel M Hawley; Elaine M Pascoe; Matthew Burrage; Rodel Leano; Brian A Haluska; Thomas H Marwick; Tony Stanton
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 5.  The myocardial oxygen supply:demand index revisited.

Authors:  Julien I E Hoffman; Gerald D Buckberg
Journal:  J Am Heart Assoc       Date:  2014-01-21       Impact factor: 5.501

6.  Assessment of left ventricular myocardial work in Turner syndrome patients: insights from the novel non-invasive pressure-strain loop analysis method.

Authors:  Felix Sebastian Oberhoffer; Hashim Abdul-Khaliq; Anna-Maria Jung; Michael Zemlin; Tilman R Rohrer; Mohamed Abd El Rahman
Journal:  Quant Imaging Med Surg       Date:  2020-01

7.  Clinical utility of left ventricular strain, wall stress and serum brain natriuretic peptide levels in chronic hemodialysis patients.

Authors:  Abeer M Shawky; Rehab M Hamdy; Asmaa A Elmadbouly
Journal:  Egypt Heart J       Date:  2018-06-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.